These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31250132)

  • 1. Elevated lymphatic vessel density measured by Lyve-1 expression in areas of replacement fibrosis in the ventricular septum of patients with hypertrophic obstructive cardiomyopathy (HOCM).
    Jiang X; Cui J; Yang C; Song Y; Yuan J; Liu S; Hu F; Yang W; Qiao S
    Heart Vessels; 2020 Jan; 35(1):78-85. PubMed ID: 31250132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing lymphatic microvessel density in primary pterygia.
    Ling S; Liang L; Lin H; Li W; Xu J
    Arch Ophthalmol; 2012 Jun; 130(6):735-42. PubMed ID: 22801834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative fragmented QRS has a good diagnostic value on myocardial fibrosis in hypertrophic obstructive cardiomyopathy based on clinical-pathological study.
    Bi X; Yang C; Song Y; Yuan J; Cui J; Hu F; Qiao S
    BMC Cardiovasc Disord; 2020 Jun; 20(1):298. PubMed ID: 32552709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvascular Rarefaction and Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy.
    Tian H; Yang C; Song Y; Wang H; Yuan J; Cui J; Liu S; Hu F; Yang W; Jiang X; Qiao S
    Cardiology; 2018; 141(4):202-211. PubMed ID: 30820009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvascular Rarefaction and Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy: A Histopathological Comparison of Pediatric and Adult Patients.
    Zhang MK; Zhang Z; Xue H; Fan L; Wen Y
    Heart Surg Forum; 2022 Jan; 25(1):E042-E047. PubMed ID: 35238310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphangiogenesis in COPD: another link in the pathogenesis of the disease.
    Hardavella G; Tzortzaki EG; Siozopoulou V; Galanis P; Vlachaki E; Avgousti M; Stefanou D; Siafakas NM
    Respir Med; 2012 May; 106(5):687-93. PubMed ID: 22154125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphatic microvessel density as a predictive marker for the recurrence time of pterygium: a three-year follow-up study.
    Lin H; Luo L; Ling S; Chen W; Liu Z; Zhong X; Wu C; Chen W; Liu Y
    Mol Vis; 2013; 19():166-73. PubMed ID: 23378730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of detection on lymphatic microvessel, lymphatic microvessel density and vascular endothelial growth factor-C in patients with colorectal carcinoma].
    Fan YZ; Li GM; Huang GP; Li XP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):477-82. PubMed ID: 17143789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery of Hypertrophic Obstructive Cardiomyopathy in Patients With Severe Hypertrophy, Myocardial Fibrosis, and Ventricular Tachycardia.
    Borisov KV
    Ann Thorac Surg; 2018 Jul; 106(1):30-37. PubMed ID: 29534954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Yang C; Qiao S; Song Y; Liu Y; Tang Y; Deng L; Yuan J; Hu F; Yang W
    Cardiovasc Pathol; 2019; 43():107150. PubMed ID: 31639652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphangiogenesis and lymphovascular invasion diminishes prognosis in esophageal cancer.
    Schoppmann SF; Jesch B; Zacherl J; Riegler MF; Friedrich J; Birner P
    Surgery; 2013 Apr; 153(4):526-34. PubMed ID: 23294880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial mechanical remodeling after septal myectomy for severe obstructive hypertrophic cardiomyopathy.
    Moravsky G; Bruchal-Garbicz B; Jamorski M; Ralph-Edwards A; Gruner C; Williams L; Woo A; Yang H; Laczay B; Rakowski H; Carasso S
    J Am Soc Echocardiogr; 2013 Aug; 26(8):893-900. PubMed ID: 23800507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-221 is a potential biomarker of myocardial hypertrophy and fibrosis in hypertrophic obstructive cardiomyopathy.
    Huang D; Chen Z; Wang J; Chen Y; Liu D; Lin K
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31868204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstructive sleep apnea causes impairment of the carotid artery in patients with hypertrophic obstructive cardiomyopathy.
    Wang S; Cui H; Zhu C; Wu R; Meng L; Yu Q; Huang X; Xiao M; Wang S
    Respir Med; 2019 Apr; 150():107-112. PubMed ID: 30961935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally invasive septal myectomy for the treatment of hypertrophic obstructive cardiomyopathy and intrinsic mitral valve disease.
    Gilmanov DSh; Bevilacqua S; Solinas M; Ferrarini M; Kallushi E; Santarelli P; Farneti PA; Glauber M
    Innovations (Phila); 2015; 10(2):106-13. PubMed ID: 25803770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asystole and scarring of the interventricular septum in hypertrophic cardiomyopathy.
    Foley PW; Frenneaux MP; Leyva F
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):349-51. PubMed ID: 19430348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of lymphangiogenesis as assessed by immunohistochemistry for podoplanin in patients with esophageal carcinoma.
    Nakayama Y; Matsumoto K; Nagato M; Inoue Y; Katsuki T; Minagawa N; Shibao K; Tsurudome Y; Hirata K; Higure A; Sako T; Nagata N
    Anticancer Res; 2007; 27(1B):619-25. PubMed ID: 17348451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of VEGF-C expression in correlation with COX-2, lymphatic microvessel density, and clinicopathologic characteristics in human non-small cell lung cancer.
    Guo X; Chen Y; Xu Z; Xu Z; Qian Y; Yu X
    Acta Biochim Biophys Sin (Shanghai); 2009 Mar; 41(3):217-22. PubMed ID: 19280060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Septal reduction therapy using nonalcohol agent in hypertrophic obstructive cardiomyopathy: Single center experience.
    Asil S; Kaya B; Canpolat U; Yorgun H; Şahiner L; Çöteli C; Arat A; Aytemir K
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):557-565. PubMed ID: 29205803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.